Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2026-01-14 @ 3:16 PM
Study NCT ID:
NCT03151993
Status:
COMPLETED
Last Update Posted:
2025-04-02
First Post:
2017-05-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Single Bolus Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Bolus Infusion Alteplase in Patients With AIS
Sponsor:
Supergene, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-18
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-10
First Submit QC Date:
None
Study First Post Date:
2017-05-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-06
Results First Submit QC Date:
None
Results First Post Date:
2025-04-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-17
Last Update Post Date:
2025-04-02
Last Update Post Date Type:
ACTUAL